comprehensive -WSS

comprehensive

author：explore 2025-09-30 00:40:15 - browse：25

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Rock icon Freddie Mercury pre

WSS

Chemotherapy before breast cancer surgery might fuel metastasis

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

AltruBio raises $225 million to develop ulcerative colitis drug

Medical mystery: When an infection after surgery isn’t what it seems

Brain MRIs reveal impact of 'toxic stress' on Black children

'Cuddling' is just what the doctor ordered for a 200

explore

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

PBM executives asked to testify by House panel

Drug repurposing or repositioning? The language matters

Does Medicare's free annual wellness visit do any good?

Dobbs anniversary: the lost opportunity of abortion as health care

How a small hospital in rural Puerto Rico survived Hurricane Maria

In age of alternative facts, a scholarly course on calling out crap

Lifetime voting ban for felony convictions struck down in Mississippi

Hepatitis C has a cure — but many Americans still lack access to it

GSK’s asthma push continues as drug succeeds in Phase 3 trials

hotspot

AI for drug discovery: Experts on separating hype from reality

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Welsh Carson private equity firm escapes from FTC antitrust case

Brain technologies pose threats that are all too real, experts warn

Novel spinal cord stimulator treats paralysis without surgery

Brain technologies pose threats that are all too real, experts warn

Wikipedia

knowledge

focus

explore